FDA
approval
· 2022-02-18
FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
Summary
FDA approved Jubilant Cadista Pharmaceuticals' generic nitrofurantoin monohydrate/macrocrystals (ANDA) as a bioequivalent generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS))